Proliferative activity and steroid hormone receptor status in male breast carcinoma

[1]  C. Sonnenschein,et al.  Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. , 1997, Endocrinology.

[2]  E. H. Luque,et al.  Lack of relationship between the expression of hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  J. Hurlimann,et al.  Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. , 1996, European journal of cancer.

[4]  H. Sasano,et al.  Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.

[5]  L. Chiusa,et al.  DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. , 1996, Human pathology.

[6]  P. Redlich,et al.  Breast cancer in men. , 1996, The Surgical clinics of North America.

[7]  M. Loda,et al.  Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome , 1996, Cancer.

[8]  K. Schulz,et al.  Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  S. Fuqua,et al.  The role of the estrogen receptor in tumor progression , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  R. Dickson,et al.  Growth factors in breast cancer. , 1995, Endocrine reviews.

[11]  A. Cnaan,et al.  Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. , 1995, American journal of clinical pathology.

[12]  E. H. Luque,et al.  Effect of Microwave Pretreatment on Proliferating Cell Nuclear Antigen (PCNA) Immunolocalization in Paraffin Sections , 1995 .

[13]  M. Province,et al.  S‐phase fraction and nuclear size in long term prognosis of patients with breast cancer , 1994, Cancer.

[14]  E. Kalkhoven,et al.  Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor , 1994, Molecular and Cellular Endocrinology.

[15]  J. Bringer,et al.  Androgen receptor gene mutation in male breast cancer. , 1993, Human molecular genetics.

[16]  D. Neuberg,et al.  Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score , 1993, Cancer.

[17]  J. Wittliff,et al.  Bromodeoxyuridine labeling for S‐phase measurement in breast carcinoma , 1993, Cancer.

[18]  W. McGuire,et al.  Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. , 1993, Journal of the National Cancer Institute.

[19]  V. Reddy,et al.  Prognostic significance of DNA ploidy in male breast carcinoma. A retrospective analysis of 32 cases , 1992, Cancer.

[20]  W. McGuire,et al.  Prognostic factors and therapeutic decisions in axillary node-negative breast cancer. , 1992, Annual review of medicine.

[21]  Woosley Jt.  Measuring cell proliferation. , 1991 .

[22]  W. McGuire,et al.  Hormones and breast cancer , 1991, Trends in Endocrinology & Metabolism.

[23]  C. Ballaré,et al.  The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer , 1991, Cancer.

[24]  S. Ciatto,et al.  Male Breast Carcinoma: Review of a Multicenter Series of 150 Cases , 1990, Tumori.

[25]  R. Hutter.  The role of the pathologist in breast cancer management , 1990, Cancer.

[26]  J. Baak,et al.  Mitosis counting in tumors. , 1990, Human pathology.

[27]  S Friedman,et al.  Prognostic value of histologic grade nuclear components of Scarff‐Bloom‐Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas , 1989, Cancer.

[28]  J. Elias,et al.  Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. , 1989, American journal of clinical pathology.

[29]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .

[30]  W. McGuire,et al.  DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens , 1988, Cancer.

[31]  W. McGuire,et al.  Clinical correlations of steroid receptors and male breast cancer. , 1980, Cancer research.

[32]  D. Schottenfeld,et al.  Male Breast Cancer: A Clinicopathologic Study of 97 Cases , 1978, Annals of surgery.

[33]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[34]  J. Russo,et al.  Role of differentiation in the pathogenesis and prevention of breast cancer , 1997 .

[35]  S. Andreola,et al.  Prognosis of breast cancer in males: an analysis of 170 cases. , 1994, European journal of cancer.

[36]  S. Wingren,et al.  DNA content and S-phase fraction in male breast carcinomas. , 1994, Acta oncologica.

[37]  D. Thomas,et al.  Breast cancer in men. , 1993, Epidemiologic reviews.

[38]  D. Dietrich.  Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. , 1993, Critical reviews in toxicology.

[39]  Larry B. Wallnau,et al.  Statistics for the Behavioral Sciences , 1985 .